Influence of the Biofield Energy Healing Treatment on the Physicochemical and Thermal Properties of Metronidazole

Metronidazole is an antibiotic useful for the treatment of vaginosis, trichomoniasis, giardiasis, etc., which are caused by the bacteria and parasites. The research work aimed to estimate the impact of the Trivedi Effect®-Consciousness Energy Healing Treatment on the physicochemical and thermal properties of metronidazoleusing modern analytical techniques. The test sample metronidazole was divided into control and treated sample. The control sample did not receive Biofield Energy Treatment; whereas the treated sample received the Biofield Treatment remotely by a renowned Biofield Energy Healer, Dahryn Trivedi. The particle size values were significantly increased by 14.37% (d10), 9.94% (d50), 7.9% (d90), and 9.41% [D(4,3)]; hence, the specific surface area was significantly decreased by 10.58% in the treated sample compared with the control sample. The PXRD peak intensities and crystallite sizes were significantly altered ranging from -97.25% to 401.64% and -63.08% to 344.35%, respectively, however, average crystallite size was significantly increased by 24.4% in the treated sample compared with the control sample. The latent heat of fusion and latent heat of decomposition were significantly increased by 7.64% and 12.13%, respectively in the treated sample compared to the control sample. The total weight loss was decreased by 1.34%; however, the residue amount was significantly increased by 76.46% in the treated sample compared with the control sample. The Biofield Energy Treatment might generate a new polymorphic form of metronidazole which would offer better powder flow ability and more thermos table compared with the control sample. The treated metronidazole would be very useful in designing better pharmaceutical formulations that might offer better therapeutic responses against the bacterial infections in the vagina, stomach, liver, skin, joints, brain, and respiratory tract, aspiration pneumonia, fungating wounds, rosacea, abdominal infections, periodontitis, amoebiasis, etc.

The Trivedi Effect®-Consciousness Energy Healing Treatment has shown a significant effect on the particle size, surface area, crystallite size, and thermal properties of metronidazole. The particle size values in the Biofield Energy Treated metronidazole powder sample were significantly increased by 14.37%, 9.94%, 7.9%, and 9.41% at d10, d50, d90, and D(4,3) compared to the control sample. Therefore, the specific surface area of the Biofield Energy Treated powder sample was significantly decreased by 10.58% compared to the control sample. The PXRD peak intensities and crystallite sizes of the Biofield Energy Treated powder sample were significantly altered ranging from -97.25% to 401.64% and -63.08% to 344.35%, respectively compared to the control sample. The average crystallite size of the Biofield Energy Treated metronidazole powder was significantly increased by 24.4% compared with the control sample. The melting and decomposition temperature of the Biofield Energy Treated sample slightly altered compared with the control sample. However, the ?Hfusion and ?Hdecomposition were significantly increased by 7.64% and 12.13% in the treated sample compared with the control sample. The total weight loss was decreased by 1.34%; however, the residue amount was significantly increased by 76.46% in the treated sample compared with the control sample. The Tmax was altered by 2.94% in the treated sample compared with the control sample. Therefore, the Trivedi Effect®-Consciousness Energy Healing Treatment might lead to generate a new polymorphic form of metronidazole which would offer better powder flow ability, good stability, rapid-dissolving rate, and thermally more stable compared with the control sample. The Trivedi Effect®-Consciousness Energy Healing Treated metronidazole sample would be very useful in designing better pharmaceutical formulations that might offer better therapeutic responses against the bacterial infections in vagina (trichomoniasis), stomach infections (pseudomembranous colitis, giardiasis), liver, skin, joints (pelvic inflammatory disease, abscess of the ovaries and fallopian tubes), brain, and respiratory tract, aspiration pneumonia, wounds, rosacea, intra-abdominal infections, lung abscess, periodontitis, amoebiasis, oral infections, and other infections caused by the anaerobic microorganisms such as Bacteroides, Clostridium, Helicobacter pylori, Fusobacterium, Dracunculus, Peptostreptococcus, and Prevotella species, etc.